SCHEMBL16623485

SCHEMBL16623485

N=C(c1cccc(C(N)=O)c1)c1c(Nc2c(F)cccc2F)cc[nH]c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.37
CCNT1 O60563 1/20 0.35
CCND1 P24385 1/20 0.35
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
CDK7 P50613 1/20 0.35
CDK9 P50750 1/20 0.35
CCNH P51946 1/20 0.35
MNAT1 P51948 1/20 0.35
CDK6 Q00534 1/20 0.35
PRKCI P41743 1/20 0.34
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK10 P53779 1/20 0.33
ERN1 O75460 1/20 0.33
BRD4 O60885 1/20 0.32
TYK2 P29597 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623603 0.92 PARP1 (0.36) PARP1MAPK8BRD4TYK2
SCHEMBL16623511 0.91 TYK2 (0.38) PARP1TYK2CHEK1
SCHEMBL16623600 0.88 TYK2 (0.34) PARP1CCNT1CCND1CCNCCDK8
SCHEMBL17849229 0.86 F10 (0.35)
SCHEMBL16623562 0.85 LOXL2 (0.39) CDK8
SCHEMBL16726647 0.84
SCHEMBL16726656 0.82 PTGS2 (0.33) PARP1TYK2
SCHEMBL16623558 0.81 PARP1 (0.34) PARP1
SCHEMBL16623453 0.79 EGFR (0.31) PARP1
SCHEMBL17849239 0.78 HDAC1 (0.46) PARP1RAB9AKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed